These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6578395)

  • 1. In vitro lines of the BN rat promyelocytic leukemia that differ from the parent.
    Glynn S; Sullivan AK
    Leuk Res; 1983; 7(4):557-63. PubMed ID: 6578395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditions controlling long-term proliferation of Brown Norway rat promyelocytic leukemia in vitro: primary growth stimulation by microenvironment and establishment of an autonomous Brown Norway 'leukemic stem cell line'.
    Lacaze N; Gombaud-Saintonge G; Lanotte M
    Leuk Res; 1983; 7(2):145-54. PubMed ID: 6574296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the clonogenic cell population (Leuk-CFU) in the marrow of BN rats during development of a promyelocytic leukemia (BNML): an in vitro assay.
    Lanotte M; Lacaze N; Gombaud-Saintonge G
    Leuk Res; 1984; 8(1):71-80. PubMed ID: 6583462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo development of an acetyldinaline resistant subline of the BN rat acute myelocytic leukemia (BNML).
    el-Beltagi HM; Martens AC; Haroun EA; Hagenbeek A
    Leukemia; 1993 Aug; 7(8):1275-80. PubMed ID: 8350629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivariate flow karyotyping of acute myelocytic leukemia in the BNML rat model.
    Arkesteijn GJ; Martens AC; Jonker RR; Hagemeijer A; Hagenbeek A
    Cytometry; 1987 Nov; 8(6):618-24. PubMed ID: 3480794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro resistance of the brown Norway rat acute myelocytic leukemia (BNML) to lymphokine-activated killer activity.
    Gaiser JF; Kloosterman TC; Martens AC; Hagenbeek A
    Leukemia; 1993 May; 7(5):736-41. PubMed ID: 8483327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.
    Collins SJ; Ruscetti FW; Gallagher RE; Gallo RC
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2458-62. PubMed ID: 276884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BN acute myelocytic leukemia (BNML) (a rat model for studying human acute myelocytic leukemia (AML)).
    Martens AC; Van Bekkum DW; Hagenbeek A
    Leukemia; 1990 Apr; 4(4):241-57. PubMed ID: 2195239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On growth regulation of the rat promyelocytic leukemia (BNML): growth inhibition and eradication of clonogenic cells by cholera toxin.
    Lanotte M; Hermouet S; Gombaud-Saintonge G; Dobo I
    Leuk Res; 1986; 10(11):1319-26. PubMed ID: 2432359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switch in differentiative response to maturation inducers of human promyelocytic leukemia cells by prior exposure to alkaline conditions.
    Fischkoff SA; Condon ME
    Cancer Res; 1985 May; 45(5):2065-9. PubMed ID: 3857114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blastic variants of rat promyelocytic leukemia produce neurologic disease.
    Brox A; Glynn S; Sullivan AK
    Leuk Res; 1984; 8(1):81-6. PubMed ID: 6583463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A subline of the Brown Norway myeloid leukemia in the Lewis x Brown Norway rat: in vivo growth characteristics and development of an in vitro clonogenic assay.
    Wiley JM; Yeager AM; Johnson RJ; Lanotte M
    Int J Cell Cloning; 1989 Sep; 7(5):292-302. PubMed ID: 2788672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrovirus-mediated transfer and expression of marker genes in the BN rat acute myelocytic leukemia model for the study of minimal residual disease (MRD).
    Yan Y; Martens AC; de Groot CJ; Hendrikx PJ; Valerio D; van Bekkum DW; Hagenbeek A
    Leukemia; 1993 Jan; 7(1):131-9. PubMed ID: 8418372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Minimum residual leukemic cells in genetically marked brown Norway rat myelocytic leukemia model].
    Yan Y; Martens AC; Van Bekkum DW
    Zhonghua Zhong Liu Za Zhi; 1992 Nov; 14(6):414-7. PubMed ID: 1304472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldehyde dehydrogenase involvement in a variant of the brown Norway rat acute myelocytic leukaemia (BNML) that acquired cyclophosphamide resistance in vivo.
    de Groot CJ; Martens AC; Hagenbeek A
    Eur J Cancer; 1994; 30A(14):2137-43. PubMed ID: 7857714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterisation of a cyclophosphamide resistant variant of the BNML rat model for acute myelocytic leukaemia.
    Martens AC; de Groot CJ; Hagenbeek A
    Eur J Cancer; 1991; 27(2):161-6. PubMed ID: 1827281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two new human myeloid cell lines derived from acute promyelocytic leukemia and chronic myelocytic leukemia.
    Kubonishi I; Machida K; Sonobe H; Ohtsuki Y; Akagi T; Miyoshi I
    Gan; 1983 Jun; 74(3):319-22. PubMed ID: 6576961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of in vitro and in vivo differentiation of myeloblastic leukemia of the RFM/Un mouse.
    Weinberg JB; Misukonis MA
    Cancer Res; 1984 Dec; 44(12 Pt 1):5594-8. PubMed ID: 6594193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells.
    Douer D; Koeffler HP
    J Clin Invest; 1982 Feb; 69(2):277-83. PubMed ID: 6276439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of monocytic differentiation by calcitriol (1,25-dihydroxyvitamin D3) in the human promyelocytic leukemic cell line (HL-60) in serum-free medium.
    Lee Y; Dunlap BE; Mellon WS
    Biochem Pharmacol; 1987 Nov; 36(22):3893-901. PubMed ID: 2825707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.